Sanofi (SNY) Debt/EBITDA US GAAP (year values) |
|||||||||
2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 0.98 | 0.60 | 0.55 | 0.75 | 0.77 | 1.95 | |||
Changes by years, y/y, % | -15% | -38% | -9% | +37% | +3% | -13.2% |
Sanofi. Debt/EBITDA
Sanofi. Debt/EBITDA, changes, %
Sanofi (SNY) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q4 | 2023Q4 | 2024Q1 | 2024Q1 | 2024Q2 | LTM ? | |||
Debt/EBITDA | 0.54 | 0.85 | -0.49 | -0.89 | 1.74 | 1.95 | ||
Changes by years, y/y, % | +11% | +76% | -37% | +14% | +81% | |||
Changes by quarters, q/q, % | -182% | +59% | -158% | +81% | -295% |